HBM Competitors

Delisted . USA . 
Stock . HBM Healthcare Investments
HBMBFDelisted Stock  USD 204.00  0.00  0.00%   
HBM Healthcare Inves competes with Línea Directa, SpareBank, NB Private, Aiful Corp, and Tetragon Financial; as well as few others. Analyzing HBM Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of HBM Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of HBM Healthcare competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
204.00204.00204.00
Details
Intrinsic
Valuation
LowRealHigh
173.61173.61224.40
Details
Naive
Forecast
LowNextHigh
202.11202.11202.11
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
202.01203.90205.79
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as HBM Healthcare. Your research has to be compared to or analyzed against HBM Healthcare's peers to derive any actionable benefits. When done correctly, HBM Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in HBM Healthcare Inves.

HBM Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between HBM Healthcare and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of HBM and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of HBM Healthcare Inves does not affect the price movement of the other competitor.

High positive correlations

SRMGF
+ 1.0
CEVIY
MNRHF
+ 1.0
CEVIY
MNRHF
+ 1.0
SRMGF
SVMB
+ 0.73
LNDAF
TGONF
+ 0.71
NHMAF
TGONF
+ 0.7
AIFLY
  

High negative correlations

TGONF
- 0.73
NBPVF
AIFLY
- 0.54
NBPVF
NBPVF
- 0.54
NHMAF
SVMB
- 0.42
NBPVF
NBPVF
- 0.1
LNDAF
NHMAF
- 0.02
LNDAF

Risk-Adjusted Indicators

There is a big difference between HBM OTC Stock performing well and HBM Healthcare OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HBM Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CEVIY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
LNDAF  0.17 (0.07) 0.00 (0.39) 0.00 
 0.00 
 0.00 
 0.00 
 4.49 
SRMGF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
NHMAF  4.56  0.76  0.10 (0.25) 4.78 
(6.67)
 11.06 
(6.98)
 32.96 
NBPVF  0.87  0.16  0.04  24.68  0.89 
(3.36)
 4.05 
(2.00)
 9.76 
AIFLY  0.42 (0.18) 0.00  0.64  0.00 
 0.00 
 0.00 
 0.00 
 15.35 
TGONF  0.71 (0.19) 0.00 (4.51) 0.00 
 0.00 
 1.66 
(2.65)
 6.62 
SVMB  2.34 (0.87) 0.00  0.95  0.00 
 0.00 
 0.00 
 0.00 
 45.21 
THNVF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
MNRHF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
All Fundamental Data

HBM Healthcare Competitive Analysis

The better you understand HBM Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, HBM Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across HBM Healthcare's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
HBMBF CEVIY LNDAF SRMGF NHMAF NBPVF AIFLY TGONF SVMB MNRHF
 0.00 
 204.00 
HBM
 0.00 
 5.40 
China
 0.00 
 1.51 
Línea
 0.00 
 12.43 
SpareBank
 0.00 
 5.25 
Nihon
 4.63 
 21.71 
NBPVF
 0.00 
 1.40 
Aiful
 4.21 
 17.08 
Tetragon
 0.00 
 2.25 
SavMobi
 0.00 
 25.05 
Menora
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Somewhat reliable
Very steady
Very steady
Very steady
Risky
Very steady
Dangerous
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Weakest
Weakest
Fair
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Hazard
Low
Low
Hazard
Small
Low
Low
Average
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Hold
Hold
Not Rated
Buy
Strong Sell
Sell
Strong Sell
Hold
Current Ratio
0.05
1.25
0.22
N/A
8.95
9.48
1.68
8.04
N/A
222.19
Net Asset
N/A
101.79 B
1.37 B
223.31 B
58.92 B
N/A
935.64 B
3.06 B
815
66.79 B
Profit Margin
N/A
N/A
0.0857
0.45
0.22
10.25
0.0782
0.56
N/A
0.094
EBITDA
N/A
(598.29 M)
126.74 M
N/A
16.83 B
N/A
15.68 B
130.87 M
(41.48 K)
N/A
Operating Margin
1.0
-1.69
0.13
0.59
0.33
-5.64
0.0736
0.58
N/A
N/A
Current Valuation
2.8 B
21.57 B
1.05 B
16.06 B
4.09 B
1.17 B
4.9 B
(1.72 B)
120.7 M
1.39 B
Price To Book
N/A
0.18
3.27
1.04
11.16
N/A
1.34
0.52
N/A
0.98
Retained Earnings
N/A
18.37 B
N/A
N/A
N/A
N/A
(47.71 B)
N/A
N/A
N/A
Current Asset
N/A
14.82 B
N/A
N/A
N/A
N/A
566.53 B
N/A
N/A
N/A
Beta
0.78
0.81
N/A
0.91
0.86
0.82
0.4
0.49
-17.52
0.66
Number Of Employees
11
273
2.58 K
1.43 K
972
19
2.12 K
23
1
3.19 K
Shares Outstanding
6.9 M
168.52 M
1.09 B
129.81 M
330.77 M
48.8 M
967.4 M
87.3 M
61.9 M
61.88 M
Cash Flow From Operations
(10.2 M)
(3.51 B)
88.66 M
(6.84 B)
11.1 B
176.32 M
(15.63 B)
64.3 M
(29.48 K)
1.24 B
Annual Yield
N/A
0.0826
0.0923
0.0517
0.0193
0.0345
0.0027
0.0633
N/A
0.019
Total Debt
220.55 M
36.53 B
73.9 M
46.53 B
500 M
148.18 M
197.27 B
250 M
18.07 K
1.75 B
Return On Equity
-0.18
-0.0362
0.28
0.12
0.16
0.0314
0.0721
0.0915
N/A
0.11
Z Score
4.2
N/A
9.0
N/A
3.6
3.6
N/A
1.8
N/A
N/A
Return On Asset
-0.1
-0.0038
0.0697
0.0132
0.13
-0.0095
0.0066
0.0539
-74.63
0.0087
Book Value Per Share
270.92
261.38
0.27
185.72
156.32
28.67
176.3
30.63
N/A
N/A
Current Liabilities
N/A
11.99 B
N/A
N/A
N/A
N/A
256.94 B
N/A
N/A
N/A
Total Asset
N/A
101.79 B
1.37 B
223.31 B
58.92 B
N/A
935.64 B
3.06 B
815
66.79 B
Debt To Equity
0.12
0.81
0.22
N/A
0.011
0.11
3.04
0.093
N/A
0.39
Last Dividend Paid
9.7
0.45
0.02
6.5
19.0
0.88
1.0
0.43
N/A
N/A
Shares Owned By Institutions
4.75
N/A
46.63
36.17
46.65
52.96
N/A
3.24
N/A
8.56
Market Capitalization
1.64 B
1.36 B
1.14 B
1.49 B
3.21 B
963.81 M
1.39 B
836.99 M
107.09 M
1.55 B
Price To Earning
2.54
3.34
7.7
12.5
20.79
1.69
27.27
3.61
N/A
N/A
Price To Sales
4.23
3.49
1.29
0.24
0.12
247.85
0.0105
2.02
619.0
0.37
Net Income
(78.03 M)
2.66 B
110.14 M
2.65 B
11.44 B
462.2 M
12.33 B
418.2 M
(41.48 K)
685.34 M
Earnings Per Share
-11.59
1.95
0.11
1.32
0.2
10.98
0.11
1.92
-0.001
3.44
Shares Owned By Insiders
16.89
N/A
29.45
6.87
8.73
0.21
N/A
19.3
3.58
66.03
Revenue
(378.52 M)
5.08 B
930.81 M
5.32 B
40.4 B
4.1 M
132.09 B
441.7 M
10 K
12.99 B
Working Capital
N/A
2.83 B
N/A
N/A
N/A
N/A
309.6 B
N/A
N/A
N/A
Cash And Equivalents
6.18 M
17.64 B
84.09 M
39.92 B
43.1 B
71.2 M
37.26 B
125.3 M
203
N/A
Cash Per Share
0.89
104.69
0.08
308.5
130.39
1.52
38.51
1.43
N/A
N/A
Gross Profit
(73.78 M)
4.96 B
162.75 M
5.95 B
24.14 B
5.73 M
124.86 B
611 M
7 K
2.13 B
Day Typical Price
204.0
5.4
1.51
12.43
5.25
21.71
1.4
17.08
2.25
25.05
Daily Balance Of Power
0.0
0.0
0.0
0.0
0.0
9.2 T
0.0
(9,223,372,036,855)
0.0
0.0
Period Momentum Indicator
N/A
N/A
N/A
N/A
N/A
0.96
N/A
(0.75)
N/A
N/A
Rate Of Daily Change
1.0
1.0
1.0
1.0
1.0
1.05
1.0
0.96
1.0
1.0
Day Median Price
204.0
5.4
1.51
12.43
5.25
21.71
1.4
17.08
2.25
25.05
Price Action Indicator
N/A
N/A
N/A
N/A
N/A
0.48
N/A
(0.37)
N/A
N/A
Relative Strength Index
67.94
N/A
47.7
N/A
N/A
54.59
N/A
35.0
12.97
N/A
Coefficient Of Variation
2268.57
N/A
(1,318)
N/A
1260.76
913.99
(895.48)
(654.98)
(709.77)
N/A
Mean Deviation
0.1339
N/A
0.1732
N/A
4.56
0.8698
0.4217
0.7084
2.34
N/A
Jensen Alpha
0.0099
N/A
(0.07)
N/A
0.7619
0.1648
(0.18)
(0.19)
(0.87)
N/A
Total Risk Alpha
(0.04)
N/A
(0.12)
N/A
(0.22)
(0.01)
(0.39)
(0.31)
(1.66)
N/A
Sortino Ratio
N/A
N/A
N/A
N/A
0.0981
0.0388
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
N/A
N/A
27.02
5.4
N/A
N/A
N/A
N/A
Standard Deviation
0.5418
N/A
0.6244
N/A
7.5
1.6
1.75
1.15
6.66
N/A
Kurtosis
31.87
N/A
41.1
N/A
10.7
3.67
64.95
3.7
32.91
N/A
Potential Upside
N/A
N/A
N/A
N/A
11.06
4.05
N/A
1.66
N/A
N/A
Treynor Ratio
0.2639
N/A
(0.39)
N/A
(0.25)
24.68
0.6444
(4.51)
0.9505
N/A
Maximum Drawdown
5.89
N/A
4.49
N/A
32.96
9.76
15.35
6.62
45.21
N/A
Variance
0.2935
N/A
0.3899
N/A
56.27
2.57
3.05
1.33
44.39
N/A
Market Risk Adjusted Performance
0.2739
N/A
(0.38)
N/A
(0.24)
24.69
0.6544
(4.50)
0.9605
N/A
Risk Adjusted Performance
0.028
N/A
(0.05)
N/A
0.0647
0.0824
(0.07)
(0.10)
(0.09)
N/A
Skewness
2.78
N/A
(5.49)
N/A
2.04
0.7171
(8.02)
(1.22)
(5.30)
N/A
Semi Deviation
N/A
N/A
N/A
N/A
4.78
0.8864
N/A
N/A
N/A
N/A
Information Ratio
(0.11)
N/A
(0.21)
N/A
0.068
0.0562
(0.16)
(0.23)
(0.15)
N/A
Value At Risk
N/A
N/A
N/A
N/A
(6.98)
(2.00)
N/A
(2.65)
N/A
N/A
Expected Short fall
N/A
N/A
N/A
N/A
(6.67)
(3.36)
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
N/A
N/A
5.2
2.32
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
N/A
N/A
22.81
0.7858
N/A
N/A
N/A
N/A

HBM Healthcare Competition Performance Charts

Five steps to successful analysis of HBM Healthcare Competition

HBM Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by HBM Healthcare Inves in relation to its competition. HBM Healthcare's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of HBM Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact HBM Healthcare's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to HBM Healthcare Inves, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your HBM Healthcare position

In addition to having HBM Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Emerging Markets Funds Thematic Idea Now

Emerging Markets Funds
Emerging Markets Funds Theme
Fund or Etfs that invest in markets of developing countries. The Emerging Markets Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the HBM Healthcare Inves information on this page should be used as a complementary analysis to other HBM Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in HBM OTC Stock

If you are still planning to invest in HBM Healthcare Inves check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the HBM Healthcare's history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY